NEO2734
|
|
2081072-29-7
|
Nortrachelogenin
|
|
34444-37-6
|
NCT-501
|
|
1802088-50-1
|
Neurokinin B
|
|
101536-55-4
|
Nemiralisib (GSK2269557)
|
|
1254036-71-9
|
NSC-703786
|
|
260443-89-8
|
NGP 555
|
|
1304630-27-0
|
Navarixin (SCH-527123)
|
|
473727-83-2
|
Nilotinib hydrochloride
|
|
923288-95-3
|
Norisoboldine
|
|
23599-69-1
|
Nazartinib (EGF816)
|
|
1508250-71-2
|
NCGC00378430
|
|
920650-00-6
|
Naquotinib(ASP8273)
|
|
1448232-80-1
|
NSC87877
|
|
56932-43-5
|
NVS-ZP7-4
|
|
2349367-89-9
|
NSC228155
|
|
113104-25-9
|
NE 52-QQ57
|
|
1401728-56-0
|
Neticonazole
|
|
130726-68-0
|
NPS-1034
|
|
1221713-92-3
|
Nedisertib (M3814)
|
|
1637542-33-6
|
Nodakenin
|
|
495-31-8
|
NPD8733
|
|
696655-62-6
|
Neopentylamine Hydroiodide
|
|
2733412-38-7
|
NIH-12848
|
|
959551-10-1
|
Nardosinone
|
|
23720-80-1
|
Nuzhenide
|
|
39011-92-2
|
NS13001
|
|
1063331-94-1
|
NVP-CGM097
|
|
1313363-54-0
|
Navoximod
|
|
1402837-78-8
|
NSC12
|
|
102586-30-1
|
Naporafenib
|
|
1800398-38-2
|
NIK SMI1
|
|
1660114-31-7
|
Norgestrel
|
|
6533-00-2
|
Neticonazole Hydrochloride
|
|
130773-02-3
|
Nilotinib hydrochloride monohydrate
|
|
923288-90-8
|
NMS-E973
|
|
1253584-84-7
|
N-Acetyl-O-phosphono-Tyr-Glu Dipentylamide TFA
|
|
190078-50-3
|
NSC 185058
|
|
39122-38-8
|
NITD-349
|
|
1473450-62-2
|
NVP-TNKS656
|
|
1419949-20-4
|
NVR 3-778
|
|
1445790-55-5
|
NMS-P118
|
|
1262417-51-5
|
N-(2-Acryloyloxyethyl)-N-benzyl-N,N-dimethylammonium Chloride
|
|
46830-22-2
|
Niraparib (MK-4827) tosylate
|
|
1038915-73-9
|
Nodakenetin
|
|
495-32-9
|
Naringenin chalcone
|
|
73692-50-9
|
N-Chloroacetyl-D-phenylalanine
|
|
137503-97-0
|
N,N-Bis(4-bromophenyl)-[1,1':4',1''-terphenyl]-4-amine
|
|
2205054-16-4
|
Nylidrin Hydrochloride
|
|
849-55-8
|
NL-1
|
|
188532-26-5
|
N-Acetylornithine
|
|
6205-08-9
|
Netupitant
|
|
290297-26-6
|
NT157
|
|
1384426-12-3
|
NG 52
|
|
212779-48-1
|
NHPI-PEG4-C2-NHS ester
|
|
1415328-95-8
|
Nebivolol
|
|
118457-14-0
|
N6022
|
|
1208315-24-5
|
NSC59984
|
|
803647-40-7
|
NSC45586
|
|
6300-44-3
|
N-[4-Cyano-3-(trifluoromethyl)phenyl]-2-methyloxirane-2-carboxamide
|
|
90357-51-0
|
NSC-60339
|
|
70-09-7
|
N-(Benzyloxycarbonyl)-D-serine-β-lactone
|
|
98632-91-8
|
NSC 31152
|
|
24138-83-8
|
N-(2-Carboxybenzoyl)-(+)-10,2-camphorsultam
|
|
1820570-99-7
|
N-Boc-PEG5-alcohol
|
|
1404111-67-6
|
N-(9,9-Dimethyl-9H-fluoren-2-yl)-9,9-diphenyl-9H-fluoren-2-amine
|
|
1456702-56-9
|
NCC007
|
|
2342583-66-6
|
N1,N3-Bis(2,2,6,6-tetramethylpiperidin-4-yl)isophthalamide
|
|
42774-15-2
|
NSC15364
|
|
4550-72-5
|
Neuropeptide W-23 (human) TFA
|
|
383415-79-0
|
Noradrenaline bitartrate monohydrate
|
|
108341-18-0
|
Neuropeptide FF TFA
|
|
99566-27-5
|
N-(6-Aminohexyl)maleimide Hydrochloride
|
|
75238-09-4
|
Nivolumab (anti-PD-1)
|
|
946414-94-4
|
NDMC101
|
|
1308631-40-4
|
N-(tert-Butoxycarbonyl)-D-serine β-Lactone
|
|
126330-77-6
|
NVP-BVU972
|
|
1185763-69-2
|
NSC5844 (RE-640)
|
|
140926-75-6
|
NSC 102533
|
|
1150-59-0
|
NP-G2-044
|
|
1807454-59-6
|
NS1652
|
|
1566-81-0
|
NSAH
|
|
1099592-35-4
|
N-Acetyl-O-phosphono-Tyr-Glu-Glu-Ile-Glu TFA
|
|
159439-02-8
|
NAcM-OPT
|
|
2089293-61-6
|
Naltrexone HCl
|
|
16676-29-2
|
NSC 55655
|
|
36140-65-5
|
N-(4-Bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine
|
|
1644059-09-5
|
NOD-IN-1
|
|
132819-92-2
|
NSC 80538
|
|
370-26-3
|
Nα-tert-Butoxycarbonyl-Nε-tetradecanoyl-L-lysine
|
|
2173052-71-4
|
N-[4-(tert-Butyl)phenyl]-9,9-dimethyl-9H-fluoren-2-amine
|
|
944418-46-6
|
NEDD8 inhibitor M22
|
|
864420-54-2
|
N-Allyl-N-tert-butylamine
|
|
16486-68-3
|
NMDAR antagonist 1
|
|
2220162-06-9
|
NSC 31205
|
|
6320-51-0
|
[Nphe1]Nociceptin(1-13)NH2 TFA
|
|
267234-08-2
|
NSC-41589
|
|
6310-41-4
|
Neuropeptide AF (human) TFA
|
|
192387-38-5
|
NVP-VID-400
|
|
174262-13-6
|
NVP-BSK805 2HCl
|
|
1942919-79-0
|